ANNX
Annexon Makes Groundbreaking Advances in Neuroinflammatory Diseases with Revolutionary New Treatments
Annexon, a pioneering biotech company, has made significant strides in its mission to tackle some of the most pressing neuroinflammatory diseases affecting millions worldwide. At the recent Q2 2026 conference call, Doug Love, President and Chief Executive Officer, highlighted the company's unwavering commitment to developing innovative treatments that